The pandemic spurred the diagnostics industry to consider aspects like scale, affordability, speed and portability of tests.
Academic rigour, journalistic flair
Articles on CRISPR
Displaying 1 - 20 of 115 articles
At the Third International Summit on Human Genome Editing, experts gather to discuss the path forward for CRISPR and other gene-editing technologies
Following the controversial births of the first gene-edited babies, a major focus of the Third International Summit on Human Genome Editing was responsible use of CRISPR.
Scientific and public uproar resulted when the Chinese scientist announced the births of the first human babies with heritable edits to their genes. A new documentary reexamines the saga.
The negative health effects of Y chromosome loss could be one potential reason women tend to live longer than men.
As genetic engineering and DNA manipulation tools like CRISPR continue to advance, the distinction between what science ‘could’ and ‘should’ do becomes murkier.
New developments in organ transplants from animals show promise. However, there has been no public engagement about a potential risk. It may streamline a pathway to humans for new zoonotic diseases.
The rapid rate of species declines means we should trial potential solutions before it’s too late.
Hox genes make sure all your body parts grow in the right place. Understanding how they work can reveal the process of evolution and lead to potential treatments for congenital birth defects.
Field trials of genetically edited crop plants are to be allowed in England under new government proposals.
Catherine Price, sociologist, and Nicola Patron, synthetic plant biologist, discuss the promises, dangers and concerns around gene edited and GM crops.
Three pioneering technologies have forever altered how researchers do their work and promise to revolutionize medicine, from correcting genetic disorders to treating degenerative brain diseases.
The sketchy history of international efforts to control bioweapons suggests that nations will resist cooperative monitoring of gene hacking for medical research.
Researchers have grown the first human-monkey hybrid embryos as well as mouse embryos in artificial wombs late into development. These biomedical breakthroughs raise different ethical quandaries.
RNA was used to make COVID vaccines. Now it could lead to more personalised healthcare.
As the world has focused on the COVID-19 pandemic, other microbial foes are waging war on humans. Antibiotic-resistant bacteria pose a growing threat. But viruses may defeat them.
We propose five principles that could guide a proper ethical and legal framework for germline editing and similar technologies.
Using ‘base editing’, researchers have cured progeria in mice. This genetic syndrome causes premature ageing in humans – those with the disease usually don’t live past the age of 13.
Canada has produced Nobel Prize winners in the arts and sciences. With several recent awards, Canadian talent still has the potential for future achievements.
We could start making our genomes equipped to deal with more frequent pandemics. But it may come at a cost.
Top contributors
-
Merlin Crossley is a Friend of The Conversation.Deputy Vice-Chancellor Academic Quality and Professor of Molecular Biology, UNSW Sydney
-
Associate professor, Queensland University of Technology
-
Distinguished Research Professor, Emerita, Dalhousie University
-
Geneticist and Group Leader, The John Curtin School of Medical Research, Australian National University
-
Assistant Professor in Biomedical Ethics, National University of Singapore
-
Doctoral Student in Biochemistry, University of Washington
-
Emeritus Robert Reford Professor and Professor of Medicine, McGill University
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Research fellow, The University of Queensland
-
Associate Professor of Public Policy and Women's Studies, University of Michigan
-
Professor of Chemistry, Connecticut College
-
Postdoctoral fellow, Harvard University
-
Postdoctoral Associate in Science and Society, Duke University
-
Emeritus Professor of Developmental Biology, The University of Queensland
-
Research fellow, The University of Queensland
